Countdown to Astrazeneca (AZN) Q4 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 02/05/26
AstraZeneca to Report Q4 Earnings: What's in Store for the Stock?Zacks Investment Research • 02/05/26
FDA Rejects AZN's Saphnelo SubQ Formulation, Priority Tag to DatrowayZacks Investment Research • 02/04/26
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovationCNBC • 02/01/26
University of Virginia Signs Master Research Collaboration Agreement with AstraZeneca to Accelerate Pre-Clinical InnovationGlobeNewsWire • 01/28/26
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare PlanZacks Investment Research • 01/19/26